AURKB and cancer: Results from these studies showed a functional relationship between AURKB inhibition and excessive generation of reactive oxygen species (ROS) in therapeutic modalities of cancer, as a mechanism of cytotoxicity induced by the aurora kinase inhibitor, Barasertib29.